
Quarterly Result2 Jul 2026, 09:30 pm
Dipna Pharmachem Declares FY26 Audited Results
AI Summary
Dipna Pharmachem Ltd announced its audited financial results for the quarter and year ended March 31, 2026. The company's Board of Directors approved the results in a meeting held on July 2, 2026. Key approvals included the audited financial results for the period and a statement of deviations for the proceeds of a preferential issue of convertible warrants. The company also adopted IND AS for its financial reporting.
Key Highlights
- Board approved audited financial results for FY26.
- Statement of deviations for preferential issue approved.
- Company adopted IND AS for financial reporting.
- Net profit for FY26 stood at ₹263.19 Lakhs.
- Total income for FY26 was ₹12,910.87 Lakhs.
Price Impact
More from DPL